Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells therapy(Etablissement Français Du Sang)

N/A

Report date: 2024/09/25 20:00:35

Base Information

Drug NameAllogenic Adipose Tissue-derived Mesenchymal Stromal Cells therapy(Etablissement Français Du Sang)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEtablissement Français Du Sang
China Registration ClassN/A

Develop Information

Active CompaniesEtablissement Français Du Sang
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A